hydroxychloroquine and rivaroxaban

hydroxychloroquine has been researched along with rivaroxaban in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bazzan, M; Radin, M; Roccatello, D; Sciascia, S	1
Hsu, YW; Juan, CJ; Lai, CH; Lee, JT; Lin, YK; Yang, FC	1
Azarfar, A; Bhanusali, N; Kong, SS	1

Reviews

2 review(s) available for hydroxychloroquine and rivaroxaban

Article	Year
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome. Internal and emergency medicine, 2017, Volume: 12, Issue:1 Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Female; Fibrinolytic Agents; Humans; Hydroxychloroquine; Lupus Coagulation Inhibitor; Pregnancy; Pregnancy Complications; Risk Assessment; Rivaroxaban; Thrombosis	2017
Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review. Rheumatology international, 2021, Volume: 41, Issue:5 Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Factor Xa Inhibitors; Female; Humans; Hydroxychloroquine; Rivaroxaban; Skin; Sneddon Syndrome	2021

Article

Year

Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome.

Internal and emergency medicine, 2017, Volume: 12, Issue:1

Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Female; Fibrinolytic Agents; Humans; Hydroxychloroquine; Lupus Coagulation Inhibitor; Pregnancy; Pregnancy Complications; Risk Assessment; Rivaroxaban; Thrombosis

2017

Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review.

Rheumatology international, 2021, Volume: 41, Issue:5

Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Factor Xa Inhibitors; Female; Humans; Hydroxychloroquine; Rivaroxaban; Skin; Sneddon Syndrome

2021

Other Studies

1 other study(ies) available for hydroxychloroquine and rivaroxaban

Article	Year
Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Complicated With Antiphospholipid Syndrome and Cerebral Venous Thrombosis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:5 Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiphospholipid Syndrome; Antirheumatic Agents; Brain; Cerebral Veins; Diagnosis, Differential; Factor Xa Inhibitors; Humans; Hydroxychloroquine; Intracranial Thrombosis; Magnetic Resonance Imaging; Male; Plasma Exchange; Receptors, N-Methyl-D-Aspartate; Rivaroxaban; Treatment Outcome; Young Adult	2017

Article

Year

Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Complicated With Antiphospholipid Syndrome and Cerebral Venous Thrombosis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:5

Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiphospholipid Syndrome; Antirheumatic Agents; Brain; Cerebral Veins; Diagnosis, Differential; Factor Xa Inhibitors; Humans; Hydroxychloroquine; Intracranial Thrombosis; Magnetic Resonance Imaging; Male; Plasma Exchange; Receptors, N-Methyl-D-Aspartate; Rivaroxaban; Treatment Outcome; Young Adult

2017